Does EPIRUBICIN Cause Malignant neoplasm progression? 513 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 513 reports of Malignant neoplasm progression have been filed in association with EPIRUBICIN (Ellence). This represents 3.2% of all adverse event reports for EPIRUBICIN.
513
Reports of Malignant neoplasm progression with EPIRUBICIN
3.2%
of all EPIRUBICIN reports
104
Deaths
63
Hospitalizations
How Dangerous Is Malignant neoplasm progression From EPIRUBICIN?
Of the 513 reports, 104 (20.3%) resulted in death, 63 (12.3%) required hospitalization, and 35 (6.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPIRUBICIN. However, 513 reports have been filed with the FAERS database.
What Other Side Effects Does EPIRUBICIN Cause?
Nausea (1,265)
Vomiting (978)
Myelosuppression (934)
Neutropenia (926)
White blood cell count decreased (873)
Febrile neutropenia (809)
Diarrhoea (749)
Asthenia (732)
Pyrexia (729)
Fatigue (685)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which EPIRUBICIN Alternatives Have Lower Malignant neoplasm progression Risk?
EPIRUBICIN vs EPLERENONE
EPIRUBICIN vs EPLONTERSEN
EPIRUBICIN vs EPOETIN ALFA-EPBX
EPIRUBICIN vs EPOGEN
EPIRUBICIN vs EPOPROSTENOL